|
1
|
Zhang H, Wang FW, Yao LL and Hao AJ:
Microglia - friend or foe. Front Biosci (Schol Ed). 3:869–883.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith JA, Das A, Ray SK and Banik NL: Role
of pro-inflammatory cytokines released from microglia in
neurodegenerative diseases. Brain Res Bull. 87:10–20. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernardi A, Frozza RL, Meneghetti A, et
al: Indomethacin-loaded lipid-core nanocapsules reduce the damage
triggered by Aβ1–42 in Alzheimer’s disease models. Int J
Nanomedicine. 7:4927–4942. 2012.PubMed/NCBI
|
|
4
|
Sung YH, Kim SC, Hong HP, et al: Treadmill
exercise ameliorates dopaminergic neuronal loss through suppressing
microglial activation in Parkinson’s disease mice. Life Sci.
91:1309–1316. 2012.
|
|
5
|
Dibaj P, Zschüntzsch J, Steffens H, et al:
Influence of methylene blue on microglia-induced inflammation and
motor neuron degeneration in the SOD1(G93A) model for ALS. PLoS
One. 7:e439632012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yulug B, Kilic U, Kilic E and Bähr M:
Rifampicin attenuates brain damage in focal ischemia. Brain Res.
996:76–80. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paunescu E: In vivo and in vitro
suppression of humoral and cellular response by rifampicin. Nature.
228:1188–1189. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nilsson BS: Rifampicin: an
immunosuppressant? Lancet. 2:3741971. View Article : Google Scholar
|
|
9
|
Dajani BM, Canadi MS, Thompson JS and
Kasik JE: Rifampicin: an immunosuppressant? Lancet. 2:19041972.
|
|
10
|
Bi W, Zhu L, Wang C, et al: Rifampicin
inhibits microglial inflammation and improves neuron survival
against inflammation. Brain Res. 1395:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singer CA, Figueroa-Masot XA, Batchelor
RH, et al: The mitogen-activated protein kinase pathway mediates
estrogen neuroprotection after glutamate toxicity in primary
cortical neurons. J Neurosci. 19:2455–2463. 1999.
|
|
12
|
Kiefer T, Hirt C, Schüler F, et al:
Statistical analysis of results obtained by real-time PCR for
improvement of absolute quantification of target sequences. Clin
Lab. 58:465–470. 2012.PubMed/NCBI
|
|
13
|
Bureau G, Longpré F and Martinoli MG:
Resveratrol and quercetin, two natural polyphenols, reduce
apoptotic neuronal cell death induced by neuroinflammation. J
Neurosci Res. 86:403–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kloss CU, Bohatschek M, Kreutzberg GW and
Raivich G: Effect of lipopolysaccharide on the morphology and
integrin immunoreactivity of ramified microglia in the mouse brain
and in cell culture. Exp Neurol. 168:32–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Namba Y, Kawatsu K, Izumi S, Ueki A and
Ikeda K: Neurofibrillary tangles and senile plaques in brain of
elderly leprosy patients. Lancet. 340:9781992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chui DH, Tabira T, Izumi S, Koya G and
Ogata J: Decreased beta-amyloid and increased abnormal Tau
deposition in the brain of aged patients with leprosy. Am J Pathol.
145:771–775. 1994.PubMed/NCBI
|
|
17
|
Tomiyama T, Kaneko H, Kataoka K, et al:
Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides
by binding to peptide fibrils and preventing amyloid-cell
interaction. Biochem J. 322:859–865. 1997.
|
|
18
|
Tomiyama T, Shoji A, Kataoka K, et al:
Inhibition of amyloid beta protein aggregation and neurotoxicity by
rifampicin. Its possible function as a hydroxyl radical scavenger.
J Biol Chem. 271:6839–6844. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tomiyama T, Asano S, Suwa Y, et al:
Rifampicin prevents the aggregation and neurotoxicity of amyloid
beta protein in vitro. Biochem Biophys Res Commun. 204:76–83. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kapurniotu A: Targeting alpha-synuclein in
Parkinson’s disease. Chem Biol. 11:1476–1478. 2004.
|
|
21
|
Bradbury J: New hope for mechanism-based
treatment of Parkinson’s disease. Drug Discov Today. 10:80–81.
2005.PubMed/NCBI
|
|
22
|
Oida Y, Kitaichi K, Nakayama H, et al:
Rifampicin attenuates the MPTP-induced neurotoxicity in mouse
brain. Brain Res. 1082:196–204. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu J, Wei C, Xu C, Bennett MC, Zhang G, Li
F, et al: Rifampicin protects PC12 cells against
MPP+-induced apoptosis and inhibits the expression of an
alpha-synuclein multimer. Brain Res. 1139:220–225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen S, Sun Y, Zeng Z and Tao E:
Rifampicin inhibits apoptosis in rotenone-induced differentiated
PC12 cells by ameliorating mitochondrial oxidative stress. Neural
Regen Res. 5:251–256. 2010.
|
|
25
|
Ozato K, Tsujimura H and Tamura T:
Toll-like receptor signaling and regulation of cytokine gene
expression in the immune system. Biotechniques. (Suppl): 66–68.
7072 passim. 2002.PubMed/NCBI
|
|
26
|
Bi W, Jing X, Zhu L, Liang Y, Liu J, Yang
L, Xiao S, et al: Inhibition of 26S protease regulatory subunit 7
(MSS1) suppresses neuroinflammation. Plos One. 7:e361422012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Broad A, Jones DE and Kirby JA: Toll-like
receptor (TLR) response tolerance: a key physiological ‘damage
limitation’ effect and an important potential opportunity for
therapy. Curr Med Chem. 13:2487–2502. 2006.
|
|
28
|
Medzhitov R: Toll-like receptors and
innate immunity. Nat Rev Immunol. 1:135–145. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brown GC and Neher JJ: Inflammatory
neurodegeneration and mechanisms of microglial killing of neurons.
Mol Neurobiol. 41:242–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Polazzi E and Monti B: Microglia and
neuroprotection: from in vitro studies to therapeutic applications.
Prog Neurobiol. 92:293–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shie FS, Chen YH, Chen CH and Ho IK:
Neuroimmune pharmacology of neurodegenerative and mental diseases.
J Neuroimmune Pharmacol. 6:28–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Liu L, Barger SW, Mrak RE and
Griffin WS: Vitamin E suppression of microglial activation is
neuroprotective. J Neurosci Res. 66:163–170. 2001. View Article : Google Scholar : PubMed/NCBI
|
